comparemela.com

Latest Breaking News On - Osterweis capital management - Page 4 : comparemela.com

Farmers & Merchants Trust Co of Chambersburg PA Has $1 18 Million Stock Position in Bristol-Myers Squibb (NYSE:BMY)

Farmers & Merchants Trust Co of Chambersburg PA grew its position in Bristol-Myers Squibb (NYSE:BMY – Free Report) by 2.8% in the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 20,345 shares of the biopharmaceutical company’s stock after acquiring an additional 550 shares during […]

Bristol-Myers Squibb (NYSE:BMY) Shares Sold by Ziegler Capital Management LLC

Bristol-Myers Squibb (NYSE:BMY) Shares Sold by Ziegler Capital Management LLC
etfdailynews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from etfdailynews.com Daily Mail and Mail on Sunday newspapers.

Bristol-Myers Squibb to Post Q4 2023 Earnings of $1 72 Per Share, Zacks Research Forecasts (NYSE:BMY)

Bristol-Myers Squibb to Post Q4 2023 Earnings of $1 72 Per Share, Zacks Research Forecasts (NYSE:BMY)
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

Baldwin Brothers LLC MA Trims Stock Holdings in Bristol-Myers Squibb (NYSE:BMY)

Baldwin Brothers LLC MA reduced its stake in Bristol-Myers Squibb (NYSE:BMY – Free Report) by 16.2% during the 3rd quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 11,130 shares of the biopharmaceutical company’s stock after selling 2,151 shares during the period. Baldwin Brothers LLC […]

Bristol-Myers Squibb (NYSE:BMY) Shares Sold by Principal Street Partners LLC

Principal Street Partners LLC cut its holdings in shares of Bristol-Myers Squibb (NYSE:BMY – Free Report) by 4.2% during the second quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 74,655 shares of the biopharmaceutical company’s stock after selling 3,290 shares during the quarter. […]

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.